Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Cost-effectiveness

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

If VADs and ECMO are to become part of routine care, they need to demonstrate that they are cost-effective. Otherwise, the time and money they consume would be better spent elsewhere in the health system. A cost-effective therapy is one that provides value for money in terms of the healthy life years gained for the costs incurred. The lives saved by VADs and ECMO need to be balanced against their relatively high cost. In this chapter we explain the key parts of a cost-effectiveness analysis using examples from published studies of VADs and ECMO.

Description

Citation

Source

Book Title

Entity type

Access Statement

License Rights

Restricted until